A new law in Louisiana has come into effect that classifies abortion pills, including misoprostol and mifepristone, as controlled dangerous substances (CDS). This legislative change mandates that such medications must be stored securely, even in situations where immediate access may be required for emergency care. Healthcare professionals have expressed serious concerns regarding the implications of this law, warning it could endanger women's lives by restricting access to essential medications. The state’s decision signals a trend towards increasing abortion restrictions that may be followed by other conservative states. Hospitals like Ochsner and LCMC Health are preparing to implement these changes, raising alarms about the potential impacts on patient care.